Target: Heather Bresch, Mylan CEO
Goal: Lower the cost of life-saving EpiPens after a 450% increase in their price and a 671% increase in Mylan executives’ salaries.
The cost of EpiPens is currently more than $600, an increase of 450% percent since 2004. Meanwhile executives at the company behind EpiPen, Mylan, have seen a more than 670% increase in their salaries. Heather Bresch, Mylan CEO, has seen her salary increase from $2.4 million to $18.9 million. By increasing the price of EpiPens, executives have given themselves a major pay raise and have left millions of families with no other option but to pay hundreds of dollars for something that may save the lives of their loved ones.
What makes this practice so unethical is that Mylan’s EpiPen is the only device on the market that can save people suffering from fatal allergic reactions. While there is a generic version of the device, doctors do not recommend it due to dosage discrepancies and most professionals are only trained in the use of EpiPen. Mylan executives have taken advantage of this scenario, increasing the price and knowing fully well that consumers have no other option. In addition, the cost of the actual medication within the pen is only about one dollar. Mylan is making a tremendous profit as a result.
Members of Congress, both Republicans and Democrats, have already demanded a bipartisan investigation into the price hike by Mylan. However, Mylan has placed blame on the “insurance landscape” for the high cost of EpiPens. Sign the petition to demand that Mylan executives take full responsibility for the price hike, lower the cost of the life-saving medication, and cut the salaries they earned at the hands of struggling American families.
Dear Ms. Bresch,
Your company, Mylan, is the sole company behind the life-saving EpiPen. Millions of families depend on your product in order to save the lives of loved ones suffering from fatal allergic reactions. However, your company has made the price of the medicine unmanageable. Something that was only $112 years ago is now more than $600. Meanwhile, your salary has risen 671%, to $18.9 million.
You and your company have taken advantage of millions of consumers. Knowing that your product is the only one they can turn to, you have raised its price to unmanageable levels and have given yourself a raise in the process. There is no reason for the EpiPen, the dosage of which only costs one dollar to your company, to cost more than $600 to consumers.
This is not only an unethical situation, but a dangerous one. If families cannot afford the EpiPen, they may resort to means of creating their own devices, or forgoing the medicine altogether. I demand that you take action to lower the cost of this medicine so that families can afford this life-saving device, even if that means giving yourselves pay cuts in the process.
[Your Name Here]
Photo Credit: Greg Friese